Kura Oncology
The role leads clinical study protocol development, collaborates with cross‑functional experts to design and execute trials, and supports regulatory document preparation and data interpretation. It also involves presenting study results internally and externally, overseeing safety and efficacy monitoring, and contributing to translational medicine initiatives.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
Right around the average for this role
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Director, Clinical Science
Pathos
Director, Clinical Science
Lyell Immunopharma
Director, Clinical Development AID
CRISPR Therapeutics
Sr. Clinical Scientist/Clinical Monitor
Workforce Genetics
R&D - TMU - Clinical Lead, Early Clinical & Experimental Therapeutics - SH
Sanofi
Director, Clinical Development
Avalyn Pharma